What Chronic Lymphocytic Leukemia Patients Should Know about Richter Syndrome with Erin Parry, MD, PhD
Richter syndrome, or Richter transformation, is a rare but serious transformation of chronic lymphocytic leukemia to a more aggressive lymphoma. Join us for this virtual webinar with Dr. Erin Parry, a hematologist oncologist specializing in treating and researching chronic lymphocytic leukemia and lymphomas.
Dalton introduces the agenda of the event and featured speaker Erin Parry, MD, PhD
Dr. Erin Parry shares about richter syndrome for chronic lymphocytic leukemia patients
Type your questions in the chat, and Dr. Jacobs will answer them!
Erin Parry, MD, PhD
Dr. Parry attended Johns Hopkins University School of Medicine where she earned an MD and a PhD. Upon graduation from medical school, Dr. Parry completed residency training in internal medicine at the Johns Hopkins Hospital followed by medical oncology fellowship at Dana-Farber/Partners CancerCare. During her fellowship, Dr. Parry conducted post-doctoral research in the laboratory of Dr. Catherine Wu on Richter transformation of chronic lymphocytic leukemia (CLL). Dr. Parry is currently an Assistant Professor of Medicine at Harvard Medical School and a Physician at Dana-Farber Cancer Institute in the Lymphoma Program and the Center for Chronic Lymphocytic Lymphoma. She runs a laboratory focused on the transformation of indolent B cell malignancies to aggressive lymphoma and mechanisms of immune evasion in CLL and B cell lymphoma.
Dalton Bean
Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.